Related Experiment Video
Updated: Jan 10, 2026

03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.0K
Causal associations between sarcopenia and Parkinson's disease ‒ A two-sample Mendelian randomization study
Nutricion Hospitalaria
|November 28, 2025
Summary
This study found that genetically predicted low muscle strength is associated with a reduced risk of Parkinson's disease (PD). However, muscle mass and walking pace showed no significant causal link to PD risk.
Area of Science:
- Neurology
- Genetics
- Gerontology
Background:
- Sarcopenia, the loss of muscle mass and function, is prevalent in Parkinson's disease (PD).
- The causal relationship between sarcopenia and PD risk remains unclear.
Purpose of the Study:
- To investigate the potential causal associations between sarcopenia-related traits and Parkinson's disease (PD) risk.
- Utilizing a two-sample Mendelian randomization (MR) approach.
Main Methods:
- Extracted genome-wide association study (GWAS) data for PD and sarcopenia traits (handgrip strength, appendicular lean mass, walking pace).
- Performed MR analyses using inverse-variance-weighted, MR-Egger, weighted-median, and weighted-mode methods.
- Conducted sensitivity analyses to assess for horizontal pleiotropy.
Main Results:
- Genetically predicted low handgrip strength was significantly associated with a reduced risk of PD (IVW OR = 0.66, p = 0.01).
- No significant causal associations were found between appendicular lean mass or usual walking pace and PD risk.
- Sensitivity analyses indicated that the results were robust and not significantly affected by horizontal pleiotropy.
Conclusions:
- Low muscle strength, a component of sarcopenia, may have a protective causal effect against Parkinson's disease (PD) development.
- Appendicular lean mass and walking pace do not appear to have a significant causal relationship with PD risk.
- Further research is warranted to elucidate the underlying mechanisms connecting muscle strength and PD pathogenesis.
Related Concept Videos
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K

